[go: up one dir, main page]

JP7766899B2 - 神経障害を処置するのに使用するためのナノ粒子 - Google Patents

神経障害を処置するのに使用するためのナノ粒子

Info

Publication number
JP7766899B2
JP7766899B2 JP2019533316A JP2019533316A JP7766899B2 JP 7766899 B2 JP7766899 B2 JP 7766899B2 JP 2019533316 A JP2019533316 A JP 2019533316A JP 2019533316 A JP2019533316 A JP 2019533316A JP 7766899 B2 JP7766899 B2 JP 7766899B2
Authority
JP
Japan
Prior art keywords
nanoparticles
stimulation
nanoparticle
brain
nanoparticle aggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019533316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020503306A (ja
Inventor
メイル，マリー－エディット
ポティエ，アニエス
レヴィ，ローラン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanobiotix SA
Original Assignee
Nanobiotix SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix SA filed Critical Nanobiotix SA
Publication of JP2020503306A publication Critical patent/JP2020503306A/ja
Priority to JP2023039403A priority Critical patent/JP2023075268A/ja
Application granted granted Critical
Publication of JP7766899B2 publication Critical patent/JP7766899B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Social Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Manufacturing & Machinery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2019533316A 2016-12-21 2017-12-19 神経障害を処置するのに使用するためのナノ粒子 Active JP7766899B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023039403A JP2023075268A (ja) 2016-12-21 2023-03-14 神経障害を処置するのに使用するためのナノ粒子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16306750 2016-12-21
EP16306750.7 2016-12-21
PCT/EP2017/083533 WO2018114945A1 (fr) 2016-12-21 2017-12-19 Nanoparticules destinées à être utilisées pour traiter un trouble neuronal

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023039403A Division JP2023075268A (ja) 2016-12-21 2023-03-14 神経障害を処置するのに使用するためのナノ粒子

Publications (2)

Publication Number Publication Date
JP2020503306A JP2020503306A (ja) 2020-01-30
JP7766899B2 true JP7766899B2 (ja) 2025-11-11

Family

ID=57850860

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019533316A Active JP7766899B2 (ja) 2016-12-21 2017-12-19 神経障害を処置するのに使用するためのナノ粒子
JP2023039403A Pending JP2023075268A (ja) 2016-12-21 2023-03-14 神経障害を処置するのに使用するためのナノ粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023039403A Pending JP2023075268A (ja) 2016-12-21 2023-03-14 神経障害を処置するのに使用するためのナノ粒子

Country Status (13)

Country Link
US (2) US11278723B2 (fr)
EP (1) EP3558373A1 (fr)
JP (2) JP7766899B2 (fr)
KR (2) KR102742371B1 (fr)
CN (2) CN110382004A (fr)
AU (1) AU2017384425B2 (fr)
BR (1) BR112019012984A2 (fr)
CA (1) CA3047649A1 (fr)
EA (1) EA201991489A1 (fr)
IL (1) IL267408B2 (fr)
MX (1) MX393038B (fr)
NZ (1) NZ755484A (fr)
WO (1) WO2018114945A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018055966A1 (fr) * 2016-09-21 2018-03-29 富士フイルム株式会社 Composition, corps façonné, stratifié, filtre de transmission pour l'infrarouge lointain, élément d'imagerie à semi-conducteurs, caméra infrarouge et capteur infrarouge
BR112019012999A2 (pt) 2016-12-21 2019-12-10 Nanobiotix nanopartículas revestidas para uso para modular a polarização elétrica de neurônios
EP3558373A1 (fr) 2016-12-21 2019-10-30 Nanobiotix Nanoparticules destinées à être utilisées pour traiter un trouble neuronal
IL305585B2 (en) 2016-12-21 2025-02-01 Nanobiotix Nanoparticles for use in improving brain performance or treating stress
MX2020006361A (es) * 2017-12-19 2020-08-17 Nanobiotix Nanoparticulas para su uso en la potenciacion del rendimiento cerebral o en el tratamiento del estres.
ES2991899T3 (es) * 2017-12-19 2024-12-05 Nanobiotix Nanopartículas para su uso para el tratamiento de un trastorno neuronal
CA3084780A1 (fr) * 2020-06-24 2021-12-24 Rodney HERRING Utilisation de nanoparticules de dioxyde de titane dopees au fer a faible teneur en oxyde de fer dans le traitement des tumeurs et autres maladies
CN117120140A (zh) * 2021-04-08 2023-11-24 诺沃库勒有限责任公司 用交变电场治疗神经退行性病症的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254419A1 (en) * 2003-04-08 2004-12-16 Xingwu Wang Therapeutic assembly
US9588124B2 (en) * 2005-05-11 2017-03-07 Georgia Tech Research Corporation Shape tunable plasmonic nanoparticles
KR100620615B1 (ko) 2005-05-23 2006-09-06 한국생명공학연구원 가시광선 영역의 색을 갖는 금속 나노입자 혼합물이 코팅된 다색 콜로이드 입자 및 그 제조방법
US20150182756A1 (en) * 2005-08-05 2015-07-02 Gholam A. Peyman Methods to regulate polarization and enhance function of cells
US10596387B2 (en) * 2007-04-08 2020-03-24 Immunolight, Llc. Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
US9358292B2 (en) * 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
TWI574712B (zh) 2008-02-21 2017-03-21 伊穆諾萊特公司 利用電漿子增強之光譜療法（ｐｅｐｓｔ）及激子-電漿增強之光療法（ｅｐｅｐ）治療細胞增生病症之組合物及產生自體疫苗之系統
US9907976B2 (en) * 2011-07-08 2018-03-06 Immunolight, Llc Phosphors and scintillators for light stimulation within a medium
US11235062B2 (en) 2009-03-06 2022-02-01 Metaqor Llc Dynamic bio-nanoparticle elements
IT1394977B1 (it) * 2009-04-14 2012-08-07 Fond Istituto Italiano Di Tecnologia Stimolazione elettrica cellulare mediata da nanotubi piezoelettrici
WO2011101039A1 (fr) * 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Appareil de traitement d'affections du cerveau et procédé pour sa mise en œuvre
WO2011127405A1 (fr) * 2010-04-08 2011-10-13 Sanford-Burnham Medical Research Institute Méthodes et compositions pour une administration améliorée de composés
GB201006841D0 (en) * 2010-04-26 2010-06-09 Thomsen Lars Method, device and system for targetted cell lysis
US8877207B2 (en) * 2010-09-17 2014-11-04 University Of Central Florida Research Foundation, Inc. Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
US20120263793A1 (en) * 2011-04-14 2012-10-18 Franco Vitaliano Bio-nano-plasmonic elements and platforms
WO2012145652A1 (fr) * 2011-04-20 2012-10-26 Trustees Of Tufts College Revêtements de soie dynamiques pour dispositifs implantables
KR102025743B1 (ko) * 2011-12-16 2019-09-26 나노비오?스 금속성 및 산화하프늄 소재를 포함하는 나노입자, 이의 제조 및 용도
US9272158B2 (en) 2012-05-22 2016-03-01 The Florida International University Board Of Trustees Method for non-invasive brain stimulation
US9242087B2 (en) * 2012-06-01 2016-01-26 The Regents Of The University Of Michigan Nanocomposites for neural prosthetics devices
ES2617528T3 (es) * 2012-06-13 2017-06-19 Cerion, Llc Nanoceria para el tratamiento de estrés oxidativo
ITRM20120350A1 (it) * 2012-07-19 2014-01-20 Univ Degli Studi Milano Nanocostrutti con attività farmacologica.
WO2014046806A1 (fr) * 2012-09-21 2014-03-27 Board Of Regents Of The University Of Texas System Pompes électro-osmotiques avec electrodes comprenant un oxyde de lanthanide ou un oxyde d'actinide
CA3251146A1 (fr) * 2013-01-25 2025-07-09 Nanobiotix Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer
WO2014202723A1 (fr) 2013-06-20 2014-12-24 Nanobiotix Compositions et procédés pour une utilisation en diagnostic médical
KR102491851B1 (ko) * 2015-07-02 2023-01-26 삼성전자주식회사 마이크로 구조체를 포함하는 플렉서블 바이모달 센서
IL305585B2 (en) 2016-12-21 2025-02-01 Nanobiotix Nanoparticles for use in improving brain performance or treating stress
EP3558373A1 (fr) 2016-12-21 2019-10-30 Nanobiotix Nanoparticules destinées à être utilisées pour traiter un trouble neuronal
BR112019012999A2 (pt) 2016-12-21 2019-12-10 Nanobiotix nanopartículas revestidas para uso para modular a polarização elétrica de neurônios

Also Published As

Publication number Publication date
AU2017384425B2 (en) 2023-08-31
WO2018114945A1 (fr) 2018-06-28
EP3558373A1 (fr) 2019-10-30
IL267408A (en) 2019-08-29
JP2020503306A (ja) 2020-01-30
MX393038B (es) 2025-03-24
CA3047649A1 (fr) 2018-06-28
BR112019012984A2 (pt) 2019-12-03
KR20230145512A (ko) 2023-10-17
US20190351231A1 (en) 2019-11-21
AU2017384425A1 (en) 2019-08-01
KR20190105592A (ko) 2019-09-17
CN110382004A (zh) 2019-10-25
US11278723B2 (en) 2022-03-22
CN115590955A (zh) 2023-01-13
US11717684B2 (en) 2023-08-08
MX2019007614A (es) 2019-09-04
JP2023075268A (ja) 2023-05-30
KR102692689B1 (ko) 2024-08-06
KR102742371B1 (ko) 2024-12-12
IL267408B1 (en) 2023-01-01
NZ755484A (en) 2023-06-30
IL267408B2 (en) 2023-05-01
US20220212008A1 (en) 2022-07-07
EA201991489A1 (ru) 2019-12-30

Similar Documents

Publication Publication Date Title
JP7766899B2 (ja) 神経障害を処置するのに使用するためのナノ粒子
US11229705B2 (en) Coated nanoparticles for use for modulating electrical polarization of neurons
JP2025163111A (ja) 神経障害を処置するのに使用するためのナノ粒子
RU2779758C2 (ru) Наночастицы для применения для лечения неврологического расстройства
HK40087255A (zh) 用於治疗神经元障碍的纳米粒子
EA044573B1 (ru) Применение наночастиц или агрегата наночастиц для лечения неврологического нарушения
HK40030220B (en) Nanoparticles for use for treating a neuronal disorder
HK40030220A (en) Nanoparticles for use for treating a neuronal disorder

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220111

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220407

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220610

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220708

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230314

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230314

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20230328

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230522

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250729

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251022

R150 Certificate of patent or registration of utility model

Ref document number: 7766899

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150